中国医药
中國醫藥
중국의약
CHINA MEDICINE
2013年
8期
1051-1052
,共2页
冠心病%心绞痛%脉血康胶囊%水蛭素
冠心病%心絞痛%脈血康膠囊%水蛭素
관심병%심교통%맥혈강효낭%수질소
Coronary heart disease%Angina pectoris%Maixuekang capsules%Hirudin
目的 观察脉血康胶囊治疗冠心病心绞痛的临床疗效.方法 选取冠心病心绞痛患者108例,按2∶1比例随机分为2组,脉血康胶囊治疗(750 mg/次,3次/d)的观察组72例,常规西药抗心绞痛治疗的对照组36例,治疗8周后,观察心绞痛症状及心电图变化.结果 观察组中心绞痛改善的总有效率为93.1％(67/72),明显优于对照组(63.9％,23/36),差异有统计学意义(P＜0.05)；观察组心电图改善的总有效率为94.4％(68/72),明显优于对照组(75.0％,27/36),差异有统计学意义(P＜0.05).结论 脉血康胶囊治疗冠心病心绞痛效果明显,在改善症状,控制和降低心绞痛发作频率方面优于西药抗心绞痛.
目的 觀察脈血康膠囊治療冠心病心絞痛的臨床療效.方法 選取冠心病心絞痛患者108例,按2∶1比例隨機分為2組,脈血康膠囊治療(750 mg/次,3次/d)的觀察組72例,常規西藥抗心絞痛治療的對照組36例,治療8週後,觀察心絞痛癥狀及心電圖變化.結果 觀察組中心絞痛改善的總有效率為93.1％(67/72),明顯優于對照組(63.9％,23/36),差異有統計學意義(P＜0.05)；觀察組心電圖改善的總有效率為94.4％(68/72),明顯優于對照組(75.0％,27/36),差異有統計學意義(P＜0.05).結論 脈血康膠囊治療冠心病心絞痛效果明顯,在改善癥狀,控製和降低心絞痛髮作頻率方麵優于西藥抗心絞痛.
목적 관찰맥혈강효낭치료관심병심교통적림상료효.방법 선취관심병심교통환자108례,안2∶1비례수궤분위2조,맥혈강효낭치료(750 mg/차,3차/d)적관찰조72례,상규서약항심교통치료적대조조36례,치료8주후,관찰심교통증상급심전도변화.결과 관찰조중심교통개선적총유효솔위93.1％(67/72),명현우우대조조(63.9％,23/36),차이유통계학의의(P＜0.05)；관찰조심전도개선적총유효솔위94.4％(68/72),명현우우대조조(75.0％,27/36),차이유통계학의의(P＜0.05).결론 맥혈강효낭치료관심병심교통효과명현,재개선증상,공제화강저심교통발작빈솔방면우우서약항심교통.
Objective To observe the clinical effects of Maixuekang capsule on coronary heart disease angina pectoris.Methods The 108 angina pectoris patients were divided into two groups.The Maixuekang capsule observation group had 72 cases and the common western medicine treatment group had 72 cases.The treatment course was 8 weeks.The symptoms of angina pectoris and transformation of electrocardiogram were observed.Results The total effective rate of angina improvement in observation group was 93.1％ (67/72),which was significantly higher than that in the control group (63.9％,23/36) ; the difference was statistically significant (P ＜ 0.05).The total effective rate of ECG improvement in observation group was 94.4％ (68/72),which was significantly higher than that in the control group (75.0％,27/36) ; the difference was statistically significant (P ＜ 0.05).Conclusions Maixuekang capsule has good effects on coronary heart disease angina pectoris regarding improving symptom,controlling and reducing frequency of angina pectoris attack and decreasing myocardial infarction.
